Medical Technology

Bioventus
Durham, North Carolina
Headquartered in Durham, N.C., Bioventus is Smith & Nephew’s former Biologics Division/Clinical Therapies business that generates about 250 million dollars in revenue annually on a worldwide basis. The product line includes the EXOGEN® Ultrasound Bone Healing System, and hyaluronic acid joint fluid therapy products, SUPARTZ® and DUROLANE®, which treat the symptoms of osteoarthritis. These innovative products provide clinical benefits to patients and cost savings to payers by delaying or eliminating the need for knee surgery. In the case of bone stimulation, expensive follow-on procedures for bone fractures which do not heal are avoided.
Contact: Guy P. Nohra
Carbylan Therapeutics, Inc.
Palo Alto, CA
Carbylan Therapeutics is developing bioresponsive medical products for osteoarthritis and chronic rhinosinusitus. The Company’s device/drug combination products are based on chemically engineered polymers of hyaluronic acid. Carbylan’s proprietary technology enables delivery for biomaterial-based medical devices as injectable liquids that self-polymerize inside the body to form therapeutic implants that covalently bind to tissues at the target delivery site.
Contact: Guy P. Nohra
USGI Medical, Inc.
San Clemente, CA
USGI Medical is focused on the development of technologies to enable advanced therapeutic procedures to be performed through the natural passageways of the GI tract.
Contact: Guy P. Nohra
Vertiflex, Inc.
Carlsbad, CA
Vertiflex is developing a line of proprietary products that will have substantial benefits for both patients and spine surgeons. Vertiflex products are focused in the area of motion preservation with an emphasis on minimally invasive approaches.
Contact: Guy P. Nohra